This page lists all known medications that could potentially lead to 'Cholestasis intrahepatic' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Intrahepatic cholestasis (ICP, also known as obstetric cholestasis) is a condition of pregnancy that commonly manifests as itching and in rare cases jaundice. It is important to evaluate the cases ...

In a new study of more than 125,000 pregnant women in Sweden, researchers at the Sahlgrenska Academy found that the risk of hepatobiliary cancer and immune-mediated and cardiovascular diseases later ...

Clinical Observations and Laboratory Findings in the Reported Cases of Benign Recurrent Intrahepatic Cholestasis. Recently, a patient was seen and studied at the Massachusetts General Hospital who had ...

Credit: Mirum Pharmaceuticals. The approval was based on data from the phase 3 MARCH-PFIC trial. The Food and Drug Administration (FDA) has approved Livmarli ® (maralixibat) for the treatment of ...

Credit: Getty Images. Bylvay is an oral reversible inhibitor of the ileal bile acid transporter. The Food and Drug Administration (FDA) has approved Bylvay™ (odevixibat) for the treatment of pruritus ...

The activity of alcohol dehydrogenase, an enzyme present principally in liver tissue, was repetitively determined in the serums of 266 patients with hepatic and nonhepatic diseases. The enzyme was ...

Drug-induced liver injury including cholestasis is another form of acquired liver disease, accounting for approximately 2 to 5% of hospitalizations for jaundice, 10% of cases of hepatitis in all ...

From 1980 to 1998, a total of 47 patients had been admitted to the Department of Pediatrics in National Taiwan University Hospital for infantile onset chronic intrahepatic cholestasis. All the ...

Intrahepatic cholestasis of pregnancy (ICP or obstetric cholestasis) may be mild and harmless but in severe cases may cause damage to the fetus. This is the reason why it needs to be treated ...

In a new study of more than 125,000 pregnant women in Sweden, researchers at the Sahlgrenska Academy found that the risk of hepatobiliary cancer and immune-mediated and cardiovascular diseases later ...